Four Fallen Stocks at ~80% Off: A 5D Comparison

There is a question making the rounds on Twitter: four stocks, all former retail darlings, all down 70-80% from their highs. Duolingo ($DUOL), Hims & Hers ($HIMS), Nike ($NKE), and PayPal ($PYPL). Which decline does the data support, and which doesn't?

It is the kind of question that invites gut reactions. Nike is a generational brand. PayPal is a household name trading at single-digit earnings. Duolingo has 40% net margins. Hims & Hers just landed a Novo Nordisk deal. Each stock has a compelling one-liner. But one-liners are how retail investors end up holding bags in the first place.

We applied the 5D Framework to all four, pulling 10 years of financial data, peer comparisons, valuation models, analyst sentiment, and smart money flows, evaluating each stock across five dimensions instead of relying on a single lens.The question is simple: does the data support or contradict each stock's decline?

Stock	Price	Market Cap	From Highs
DUOL	$96.54	$4.5B	82%
HIMS	$19.14	$4.2B	73%
NKE	$44.19	$65.3B	75%
PYPL	$45.34	$42.4B	85%

Note: DUOL and HIMS are mid-caps while NKE and PYPL are large caps. Readers should weigh the size gap when comparing across the group.

Why they are here: Duolingo's management deliberately guided bookings growth down to 10-12% for 2026, trading near-term revenue for user growth, while AI disruption fears compounded the selloff. Hims nearly blew up when the FDA resolved the GLP-1 shortage, threatening its compounded semaglutide business, before a Novo Nordisk settlement in March 2026 de-risked the immediate threat. Nike is fighting tariffs, a 17% China sales decline, and a slow turnaround under returning CEO Elliott Hill. PayPal is on its third CEO in three years after branded checkout growth stalled and 2026 profit guidance disappointed.

Four very different stories. The 5D Framework helps us see past the narratives and into the numbers.

Dimension 1: Business Quality - Do the Financials Support the Selloff?

Metric	DUOL	HIMS	NKE	PYPL
Quality Score	2.90/5	2.33/5	2.75/5	3.35/5
FY2025 Revenue	$1.04B	$2.35B	$46.3B	$33.2B
Revenue CAGR (6-9yr)	56.4%	74.7%	4.1%	13.2%
Net Margin	39.9%	5.5%	7.0%	15.8%
ROE	30.7%	23.7%	24.4%	25.8%
Free Cash Flow	$370M	$74M	$3.3B	$5.6B
Debt/Equity	0.07	2.34	0.83	0.49

DUOL: Data does not justify the selloff. Revenue grew 38.7% in FY2025 to $1.04 billion, extending a 14x expansion from $71 million (2019). Gross margins have held steady at ~72% for seven years. Operating margins improved every year, from -20% (2019) to 13.1% (2025). Free cash flow grew from negative to $370 million on a near-zero-debt balance sheet (D/E 0.07). The underlying business trajectory is unambiguously positive. The market's concerns are entirely forward-looking; nothing in 7 years of data supports them yet.

PYPL: Data does not support the degree of selloff. Growth slowed from 20.8% (2017) to 4.3% (FY2025), so the repricing from growth to mature company was justified. What the data does not support is the degree. While growth decelerated, the business became more efficient: operating margins improved from 14.6% to 18.3%, ROE hit an all-time high of 25.8%, and free cash flow grew from $2.5B to $5.6B. PayPal bought back $6.05B of stock and initiated its first dividend. The market priced in growth dying and missed that profitability was improving.

NKE: Data supports the selloff. Revenue fell 9.8% in FY2025 to $46.3 billion after peaking at $51.4 billion. Net income dropped 44%. Free cash flow fell 51%. ROIC declined from a peak of 25.2% (FY2019) to 11.6%. Every operating metric is heading in the wrong direction. The quality score of 2.75 still gives credit for a manageable balance sheet (D/E 0.83), but the fundamentals have genuinely deteriorated.

HIMS: Data partially supports the selloff. The transformation from -87% net margins in 2019 to profitability is real, and revenue expanded 28x. However, FY2025 is a mixed picture. Gross margins compressed from 82.0% (FY2023) to 73.8% and net margins dipped from 8.5% to 5.5%. Debt-to-equity spiked from 0.02 to 2.34. Free cash flow fell from $198M to $74M, but operating cash flow actually grew 20% to $300M: the FCF decline is driven by heavy capex investment, not operational deterioration. The trajectory is sharply positive, but the margin compression and leverage warrant watching.

Bottom line: Nike's selloff is fully earned. DUOL's and PYPL's are not. HIMS sits in between with a strong trajectory but fresh warning signs.

Dimension 2: Peer Comparison - How Do They Rank in Their Sectors?

Metric	DUOL (vs 56 Tech)	HIMS (vs 33 Healthcare)	NKE (vs 50 Consumer Cyclical)	PYPL (vs 69 Financial Services)
Sector Score	3.83/5	2.91/5	2.03/5	3.70/5
Revenue Growth %ile	98th	97th	10th	41st
ROE %ile	91st	75th	46th	84th
Gross Margin %ile	73rd	80th	59th	32nd
FCF Yield %ile	79th	15th	12th	74th
Debt/Equity %ile	75th (less debt)	9th (more debt)	72nd	61st
P/E %ile	98th (cheaper)	25th	34th	97th (cheaper)

Peer data reinforces the Dimension 1 findings. DUOL ranks near the top of Technology on nearly every metric. The market priced it as deteriorating; the peer data says it is one of the strongest in its sector right now. PYPL is extremely cheap relative to Financial Services with strong returns. NKE lags badly: 10th percentile on growth, 0th on operating cash flow growth, 12th on FCF yield. HIMS has the fastest growth in Healthcare (97th) but the peer data exposes real fragility: 8th percentile on leverage, 4th on operating margin.

Bottom line: DUOL and PYPL are outperforming their sectors while being priced as failures. NKE is underperforming its sector, confirming the selloff. HIMS has growth but the weakest balance sheet in its peer group.

Dimension 3: Valuation - Has the Market Priced in the Right Amount of Pessimism?

Metric	DUOL	HIMS	NKE	PYPL
P/E (TTM)	10.9x	33.9x	29.0x	8.1x
EV/EBITDA	23.9x	32.6x	21.0x	5.8x
Forward P/E (FY2026E)	32.9x	46.3x	28.9x	8.6x
FCF Yield	8.3%	1.7%	1.6%	13.1%
DCF Intrinsic Value	$330	$49	$57	$110
DCF Upside	242%	157%	29%	143%
Blended Implied Price	$239	$28	$45	$97
Blended Upside	148%	46%	2%	114%

Our model estimates PYPL priced furthest below its intrinsic-value estimate. At 8.1x P/E and 13.1% FCF yield, the stock doesn't need anything to change for the model's estimate to clear the current price. Even at zero growth, a company generating $5.6B in free cash flow at these multiples sits well under the model's estimate. The DCF ($110) uses a 7.2% growth rate, but the margin of safety is wide enough that the assumptions barely matter.

DUOL's trailing P/E of 10.9x is misleading because FY2025 net income included substantial non-operating items. The forward P/E of 32.9x is the real price tag. Still, the 8.3% FCF yield on a near-zero-debt balance sheet means an 82% haircut overshoots the fundamentals. The upside is real but growth-dependent.

NKE is not cheap despite dropping 75%. At 29.0x P/E and 1.6% FCF yield, it trades at a premium to sector medians. The blended implied price of $45 is almost exactly the current price: the model estimates NKE priced near its intrinsic-value estimate.

HIMS is priced for a future that hasn't arrived. At 33.9x P/E and 1.7% FCF yield, the margin of safety is the thinnest of the four. The DCF assumes 43.2% EBITDA margins based on analyst esimates that HIMS has never demonstrated - current EBITDA margin is just 6.8%.

Bottom line: Our model estimates PYPL and DUOL priced below their intrinsic-value estimates, NKE near its estimate, and HIMS only at prices that require optimistic assumptions.

Dimension 4: Analyst Sentiment - Does the Street Agree?

Metric	DUOL	HIMS	NKE	PYPL
Sentiment Score	2.8/5	3.0/5	3.7/5	3.0/5
Consensus	Hold	Hold	Buy	Hold
Buy / Hold / Sell	8 / 13 / 1	6 / 13 / 0	40 / 26 / 5	28 / 38 / 4
Median Price Target	$245	$27	$74	$51
Price Target Upside	147%	33%	67%	+12%

The analyst consensus contradicts the data in two important ways. NKE gets the most bullish rating despite the weakest fundamentals across Dimensions 1-3. When most analysts rate Buy on a stock with declining revenue, compressing margins, and an FCF yield of 1.6%, it suggests brand sentiment rather than current data is driving the call.

PYPL gets the most skeptical treatment despite the strongest value case. The Street is in "show me" mode on the new CEO. This creates an interesting tension: either analysts see something the backward-looking data misses, or they are slow to adjust after three years of disappointment.

DUOL has the widest disagreement ($100 to $330 range), reflecting genuine uncertainty about whether management's de-monetisation gamble will pay off. The ratings and price targets are trending downwards.

HIMS has the widest relative range ($12.50 to $60), mirroring the uncertainty in the business trajectory itself. The targets have dropped from $35 last year to $21 in the last month. The percentage of buy ratings is also trending downwards.

Bottom line: The Street is most bullish where the data is weakest (NKE) and most skeptical where the value case is strongest (PYPL). Data-driven investors should note the disconnect.

Dimension 5: Smart Money - What Are Insiders and Institutions Doing?

Who's buying?	DUOL	HIMS	NKE	PYPL
Insiders	Selling	Selling	Neutral	Selling
Institutions	Mixed	Selling	Buying	Buying
Funds	Selling	Selling	Buying	Selling
Score	1.90	1.90	3.20	2.30

The table simplifies it but the details matter. PYPL insiders have not bought a single share at 8x earnings, yet institutions are steadily accumulating with the only bullish options positioning in the group. That split is either a warning or an opportunity. NKE is the only stock where funds are net buyers, which is the real positive signal. Insiders bought and sold similar amounts each quarter, netting out to roughly flat. DUOL institutions actually built positions through most of the decline (ownership rose from 76% to 86%) before pulling back recently. HIMS is the only stock where every category is unambiguously negative: insiders have never purchased at any price, institutions reversed sharply from 89% to 81% ownership in a single quarter, and funds are dumping the heaviest volume of the four.

Bottom line: The people with the most money are buying PYPL but the people with the most information are not. HIMS is the only stock nobody wants to own. NKE and DUOL fall somewhere in between.

What the Five Dimensions Show

Dimension	DUOL	HIMS	NKE	PYPL
1. Business Quality	2.90	2.33	2.75	3.35
2. Peer Comparison	3.83	2.91	2.03	3.70
3. Valuation (blended upside)	148%	46%	2%	114%
4. Analyst Sentiment	2.80	3.00	3.70	3.00
5. Smart Money	1.90	1.90	3.20	2.30
Decline vs fundamentals	Not reflected in data	Partly reflected	Reflected in data	Not reflected in data

PayPal dropped 85% as the market repriced it from a growth company to a mature one after three CEOs and stalling branded checkout. The fundamentals support a repricing, but the data does not support its degree. At 8x earnings and 13.1% FCF yield, the model estimates the stock priced below its intrinsic-value estimate even on flat fundamentals. The question is less what has to go right than what would have to deteriorate for $5.6 billion in annual free cash flow to sit at such a discount.

Duolingo is the highest-quality business in the group and nothing in seven years of data supports the 82% drawdown. The elephant in the room is AI. If AI commoditises language learning, the quality we measured may not persist. If Duolingo's brand and product moat can coexist with AI, the data describes a business priced well below where its fundamentals would suggest. The data cannot settle that question, but it can tell you the business has not cracked yet.

Hims & Hers nearly blew up over a single FDA decision six months ago. The Novo Nordisk settlement de-risked the immediate threat, but the data exposed real fragility: highest leverage in its peer group, thinnest margins, and every category of informed investor selling. The question from the intro remains: is this a transformed business, or one regulatory shift away from the next crisis?

Nike is the stock where the data most clearly supports the selloff. Revenue declining, margins compressing, peers confirming the weakness, and at 29x earnings the model estimates it priced near its intrinsic-value estimate. The one nuance is that institutions are buying and funds are accumulating, suggesting that they see something the financials have not shown yet. That may prove right eventually, but on current data, the decline lines up with the fundamentals.

Explore each stock's full 5D analysis: DUOL | HIMS | NKE | PYPL

---

All financial data sourced from Stockoscope's database, powered by Financial Modeling Prep API. Market context informed by public reporting from Motley Fool, CNBC, Seeking Alpha, TIKR, and 24/7 Wall St. Prices and scores as of 4 April 2026.

This analysis is for informational purposes only and should not be considered personalised investment advice. Past performance does not guarantee future results.